S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

BPMC Blueprint Medicines Corporation

95.10

0.47 (0.50%)

Nov 27 2024 - Closed

Delayed by 15 minutes

Form 144/A - Report of proposed sale of securities: [Amend]

Blueprint Medicines (NASDAQ:BPMC)
Historical Stock Chart
From Oct 2024 to Nov 2024

Click Here for more Blueprint Medicines Charts.

Blueprint Medicines (NASDAQ:BPMC)
Historical Stock Chart
From Nov 2023 to Nov 2024

Click Here for more Blueprint Medicines Charts.

Blueprint Medicines Corporation News

Form 144 - Report of proposed sale of securities
Wednesday 27 November 2024 (1 day ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 22 November 2024 (6 days ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Thursday 21 November 2024 (1 week ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Wednesday 20 November 2024 (1 week ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 12 November 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 144/A - Report of proposed sale of securities: [Amend]
Tuesday 12 November 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Thursday 7 November 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Wednesday 30 October 2024 (4 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 30 October 2024 (4 weeks ago) • Edgar (US Regulatory)

Blueprint Medicines Reports Third Quarter 2024 Results and Raises AYVAKIT®/AYVAKYT® (avapritinib) Full Year Revenue Guidance
Wednesday 30 October 2024 (4 weeks ago) • PR Newswire (US)

Blueprint Medicines to Report Third Quarter 2024 Financial Results on Wednesday, October 30, 2024
Wednesday 16 October 2024 (1 month ago) • PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 4 October 2024 (2 months ago) • Edgar (US Regulatory)

More Blueprint Medicines Corporation News Articles

ERHC Energy (CE)

North Bay Resources (PK)

Kraig Biocraft Laborator... (QB)

Anavex Life Sciences

Northwest Biotherapeutics (QB)

Bioelectronics (PK)

Intergrated Cannabis Sol... (PK)

Digital Brand Media and ... (PK)

Elite Pharmaceuticals (QB)

Lightwave Logic

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions